|
|
Volumn 371, Issue 9616, 2008, Pages 932-944
|
|
Mumps
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA2B INTERFERON;
ANALGESIC AGENT;
ANTIVIRUS AGENT;
IMMUNOGLOBULIN;
IMMUNOGLOBULIN M ANTIBODY;
MEASLES MUMPS RUBELLA VACCINE;
MUMPS VACCINE;
NUCLEIC ACID;
ASEPTIC MENINGITIS;
CENTRAL NERVOUS SYSTEM INFECTION;
CLINICAL EFFECTIVENESS;
CLINICAL FEATURE;
CLINICAL TRIAL;
COHORT ANALYSIS;
DEVELOPED COUNTRY;
DIFFERENTIAL DIAGNOSIS;
DISEASE TRANSMISSION;
DRUG EFFICACY;
ENCEPHALITIS;
EPIDEMIC;
FEVER;
HEARING IMPAIRMENT;
HUMAN;
IMMUNE RESPONSE;
INFECTION PREVENTION;
INFECTION SENSITIVITY;
INJECTION SITE REACTION;
LABORATORY DIAGNOSIS;
MEASLES;
MORBIDITY;
MUMPS;
MUMPS VIRUS;
ORCHITIS;
OVARY INFLAMMATION;
PANCREATITIS;
PAROTITIS;
PATHOGENESIS;
PATHOPHYSIOLOGY;
PREGNANCY;
PRIORITY JOURNAL;
RASH;
REVIEW;
RUBELLA;
SEROLOGY;
SEROPREVALENCE;
SINGLE DRUG DOSE;
UNITED KINGDOM;
UNITED STATES;
VACCINATION;
VIRUS DETECTION;
VIRUS ISOLATION;
|
|
EID: 40649084315
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(08)60419-5 Document Type: Review |
|
Times cited : (438)
|
|
References (188)
|
